**Kura Oncology Announces Chief Medical Officer Resignation and New Appointments**SAN DIEGO, Calif.–(BUSINESS WIRE)–January 6, 2025Kura Oncology, Inc. (NASDAQ:KURA) recently disclosed in an 8-K filing a significant change in its executive leadershi
* This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Kura Oncology’s 8K filing here. Kura Oncology Company Profile (Get Free Report) Kura Oncology, Inc, a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company’s pipeline consists of […]
More Stories
Top Cryptocurrency Stocks To Watch Now – April 8th
Robinhood Markets, Bit Origin, and Bitdeer Technologies Group are the three Cryptocurrency stocks to watch today, according to MarketBeat’s stock...
Best Gold Stocks Worth Watching – April 8th
Robinhood Markets, Coca-Cola, and Freeport-McMoRan are the three Gold stocks to watch today, according to MarketBeat’s stock screener tool. Gold...
Arrowstreet Capital Limited Partnership Acquires 9,713 Shares of The Middleby Co. (NASDAQ:MIDD)
Arrowstreet Capital Limited Partnership increased its stake in shares of The Middleby Co. (NASDAQ:MIDD – Free Report) by 157.9% during...
Palomar (NASDAQ:PLMR) Upgraded at JPMorgan Chase & Co.
JPMorgan Chase & Co. upgraded shares of Palomar (NASDAQ:PLMR – Free Report) from a neutral rating to an overweight rating...
NVIDIA Co. (NASDAQ:NVDA) Shares Sold by Schrum Private Wealth Management LLC
Schrum Private Wealth Management LLC cut its stake in NVIDIA Co. (NASDAQ:NVDA – Free Report) by 56.3% in the fourth...
8,268 Shares in NVIDIA Co. (NASDAQ:NVDA) Bought by Aigen Investment Management LP
Aigen Investment Management LP acquired a new position in shares of NVIDIA Co. (NASDAQ:NVDA – Free Report) in the 4th...